Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin M Guo

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Oncotargets and Therapy|March 30, 2016
Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human gliomaAdarsh Shankar, Thaiz F Borin, Asm Iskander, et al.
Plos One|December 31, 2014
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceThaiz Ferraz Borin, Debora A P C Zuccari, Bruna V Jardim-Perassi, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Oncotargets and Therapy|March 30, 2016
Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human gliomaAdarsh Shankar, Thaiz F Borin, Asm Iskander, et al.
Plos One|December 31, 2014
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceThaiz Ferraz Borin, Debora A P C Zuccari, Bruna V Jardim-Perassi, et al.
Pageof 3